DRUGS MADE IN AMERICA ACQUIS (DMAA:NASDAQ)
$10.515 0.005 (0.0476%)
Analysed DRUGS MADE IN AMERICA ACQUIS (DMAA:NASDAQ) News Sources
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) is definitely on the radar of institutional investors who own 38% of the company
16-08-2025
yahoo.com
What is the current price of DRUGS MADE IN AMERICA ACQUIS (DMAA:NASDAQ)?
The current price of DRUGS MADE IN AMERICA ACQUIS (DMAA:NASDAQ) is $10.515.
DRUGS MADE IN AMERICA ACQUIS (DMAA:NASDAQ) absolute price change since previous trading day?
The absolute price change of DRUGS MADE IN AMERICA ACQUIS (DMAA:NASDAQ) since the previous trading day is $0.005.
DRUGS MADE IN AMERICA ACQUIS (DMAA:NASDAQ) percentage price change since previous trading day?
The percentage price change of DRUGS MADE IN AMERICA ACQUIS (DMAA:NASDAQ) since the previous trading day is 0.0476%.
What is the most recent average sentiment score for DRUGS MADE IN AMERICA ACQUIS (DMAA:NASDAQ)?
The most recent average sentiment score for DRUGS MADE IN AMERICA ACQUIS (DMAA:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for DRUGS MADE IN AMERICA ACQUIS (DMAA:NASDAQ)?
The most recent sentiment for DRUGS MADE IN AMERICA ACQUIS (DMAA:NASDAQ) is .
SEC-8K** Filing Available For DRUGS MADE IN AMERICA ACQUIS (DMAA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.